You can buy or sell MISONIX and other stocks, options, ETFs, and crypto commission-free!
MISONIX, Inc. Common Stock, also called MISONIX, is a medical device company, which engages in the design, development, manufacture and marketing of therapeutic ultrasonic medical devices. Read More Its products include the bonescalpel cutting system, which is used for surgical procedures of the spine and on maxillofacial procedures; the sonastar surgical aspirator, which is used to emulsify and remove soft and hard tumors; the sonicone wound cleansing and debridement system, which offers tissue specific debridement and cleansing of wounds for effective removal of devitalized tissue and fibrin deposits while sparing viable cells. The company's ultrasonic medical devices are used in the following surgeries: spine, neuro, orthopedic, wound debridement, cosmetic, laparoscopic, and medical applications. The company was founded by Howard Alliger in 1959 and is headquartered in Farmingdale, NY.
Farmingdale, New York
52 Week High
52 Week Low
Advertising and Marketing
Seeking AlphaMay 12
Misonix, Inc. CEO Stavros Vizirgianakis on Q3 2019 Results - Earnings Call Transcript
Misonix, Inc. (NASDAQ:MSON) Q3 2019 Results Earnings Conference Call May 8, 2019 4:30 PM ET Company Participants Norberto Aja - Investor Relations Stavros Vizirgianakis - President, CEO & Director Joe Dwyer - CFO, Treasurer & Secretary Conference Call Participants Kyle Rose - Canaccord Genuity Michael Kaufman - MK Investments Operator Good day, and welcome to the Misonix Third Quarter Fiscal Year 2019 Earnings Call. Today's conference is being recorded. At this time, I'd like to turn the conference...
Misonix (NASDAQ:MSON) Announces $97M Acquisition Of Solys Medical
Medical device maker Misonix, Inc. (NASDAQ: MSON) announced Thursday that it entered a definitive agreement to acquire privately held Solsys Medical, LLC in an all-stock transaction valued at about $97 million. What Happened Per the deal, Misonix said it will issue approximately 5.7 million new shares to Solys unitholders. After the deal closes, Misonix shareholders will own 64 percent of the combined entity and Solys unitholders will own 36 percent, according to the press release. Misonix said it will ...
Expected Sep 4, After Hours